COMPARISON OF OBTURATOR NERVE BLOCK TECHNIQUES IN TURBT
COMPARISON OF THE EFFECT OF SUBPECTINEAL OBTURATOR NERVE BLOCK AND INTERFASCIAL OBTURATOR NERVE BLOCK ON ADDUKTOR MUSCLE SPASM IN PATIENTS WHO UNDERWENT TUR-BT OPERATION
2 other identifiers
interventional
60
1 country
1
Brief Summary
Bladder cancer is one of the most common cancers in older adults. The standard treatment for many bladder tumors is a surgical procedure called transurethral resection of bladder tumor (TUR-BT). During this operation, tumors located on the side wall of the bladder may trigger an involuntary leg movement known as the "obturator reflex." This reflex occurs when electrical stimulation during surgery activates the obturator nerve, causing sudden contraction of the inner thigh (adductor) muscles. Such muscle spasms can lead to serious complications, including incomplete tumor removal or bladder perforation. To prevent this reflex, anesthesiologists perform an obturator nerve block (ONB), a procedure in which local anesthetic medication is injected around the nerve to temporarily stop its function. With advances in ultrasound technology, different ultrasound-guided techniques have been developed to perform this nerve block more safely and effectively. There are two commonly used approaches. The first is the interfacial (distal) technique, in which two separate injections are performed to block the anterior and posterior branches of the obturator nerve. The second is the subpectineal (proximal) technique, in which the nerve is blocked with a single injection at a more proximal location, potentially using a smaller amount of local anesthetic. The purpose of this study was to compare these two ultrasound-guided techniques in patients undergoing TUR-BT surgery. The aim of this study was to compare the effectiveness and safety of the subpectineal and interfacial obturator nerve block techniques in preventing adductor muscle spasm during surgery. Sixty patients aged between 50 and 80 years who were scheduled for TUR-BT were randomly assigned to receive either the subpectineal or the interfacial obturator nerve block. The main outcome measured was the occurrence and severity of adductor muscle spasm during surgery. Secondary outcomes included the number of needle insertions, duration of anesthesia and surgery, and any complications related to the block. The hypothesis of this study was that the subpectineal technique would provide comparable effectiveness in preventing adductor muscle spasm compared with the interfacial technique while requiring fewer injections and a lower volume of local anesthetic. The results of this study may help determine the most effective and practical technique for preventing surgical complications during bladder tumor surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFirst Submitted
Initial submission to the registry
March 2, 2026
CompletedFirst Posted
Study publicly available on registry
March 18, 2026
CompletedMarch 18, 2026
March 1, 2026
5 months
March 2, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence and Severity of Intraoperative Adductor Muscle Spasm
Adductor muscle spasm was evaluated intraoperatively and graded using a four-level scale (Grade I-IV), with higher grades indicating stronger contraction and possible interference with the surgical procedure.
During surgery (intraoperative period)
Secondary Outcomes (2)
Number of Needle Insertions
During the block procedure (preoperative period)
Block-Related Complications
From block procedure through end of surgery (perioperative period)
Study Arms (2)
Subpectineal Obturator Nerve Block
ACTIVE COMPARATORParticipants in this arm received an ultrasound-guided subpectineal obturator nerve block prior to transurethral resection of bladder tumor. A single injection of 10 mL of 0.375% bupivacaine was administered into the fascial plane between the pectineus and obturator externus muscles to achieve proximal blockade of the obturator nerve.
Interfacial Obturator Nerve Block
ACTIVE COMPARATORParticipants in this arm received an ultrasound-guided interfacial obturator nerve block prior to transurethral resection of bladder tumor. Two separate injections of 10 mL of 0.375% bupivacaine were administered between the adductor longus and brevis muscles and between the adductor brevis and magnus muscles to block the anterior and posterior branches of the obturator nerve.
Interventions
Ultrasound-guided single-injection obturator nerve block performed between the pectineus and obturator externus muscles using 10 mL of 0.375% bupivacaine.
Ultrasound-guided obturator nerve block performed with two separate injections between adductor muscle groups using 0.375% bupivacaine.
Eligibility Criteria
You may qualify if:
- Patients aged between 50 and 80 years
- Diagnosed with bladder tumor and scheduled for transurethral resection of bladder tumor (TURBT)
- Classified as American Society of Anesthesiologists (ASA) physical status I-III
- Provided written informed consent
You may not qualify if:
- Coagulopathy or anticoagulant therapy contraindicating regional anesthesia
- Known allergy to local anesthetics
- Infection at the injection site
- Pre-existing neuromuscular disorder affecting lower extremities
- Severe cardiac, hepatic, or renal dysfunction
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yavuz Saygılılead
Study Sites (1)
Ankara Etlik City Hospital
Ankara, Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
March 2, 2026
First Posted
March 18, 2026
Study Start
August 1, 2022
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be publicly shared due to institutional policies and patient confidentiality considerations. Data may be made available upon reasonable request to the corresponding author and subject to approval by the institutional ethics committee.